Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasma Blue is a medical technology company that has developed a proprietary process to improve the efficiency and yield of plasma collection. The company's technology utilizes a unique approach to plasma separation that significantly reduces the time required for donation while increasing the volume of plasma collected per donor. By optimizing the collection process, Plasma Blue aims to address the global shortage of plasma-derived medicinal products (PDMPs) used to treat rare and chronic diseases. The company focuses on providing its innovative solutions to plasma collection centers and pharmaceutical manufacturers to enhance their operational productivity and donor experience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasma Blue.